Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02620839 | Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies | terminated | Phase 1 | 28 | Pamela MunsterOTHER | 1 | Jan 10, 2020 | clinicaltrials |
| NCT01488513 | ABC294640 in Treating Patients With Advanced Solid Tumors(ABC-101) | completed | Phase 1 | 22 | RedHill Biopharma LimitedINDUSTRY | 1 | Jan 7, 2020 | clinicaltrials |
| NCT02003092 | RX-5902 Treatment of Subjects With Triple Negative Breast Cancer | terminated | Phase 1 / Phase 2 | 18 | Rexahn Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 6, 2020 | clinicaltrials |
| NCT00036790 | Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer | completed | Phase 1 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01445106 | A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01988896 | Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 153 | Hoffmann-La RocheINDUSTRY | 6 | Dec 17, 2019 | clinicaltrials |
| NCT03042910 | A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | PfizerINDUSTRY | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01326702 | Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors | completed | Phase 1 / Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT00004872 | Endostatin in Treating Patients With Advanced Refractory Solid Tumors | completed | Phase 1 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT00005794 | Perifosine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT00023855 | PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT00049712 | Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma | completed | Phase 1 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT02304393 | A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors | completed | Phase 1 | 140 | Hoffmann-La RocheINDUSTRY | 6 | Dec 13, 2019 | clinicaltrials |
| NCT00582816 | Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors | terminated | Phase 1 / Phase 2 | 9 | University of Wisconsin, MadisonOTHER | 1 | Dec 9, 2019 | clinicaltrials |
| NCT01954355 | LDE225 and Paclitaxel in Solid Tumors | completed | Phase 1 | 30 | Swiss Cancer InstituteOTHER | 1 | Dec 6, 2019 | clinicaltrials |
| NCT00985868 | AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors | completed | Phase 1 | 33 | Cancer Research UKOTHER | 1 | Nov 29, 2019 | clinicaltrials |
| NCT02614456 | Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors | completed | Phase 1 | 26 | Fox Chase Cancer CenterOTHER | 1 | Nov 29, 2019 | clinicaltrials |
| NCT02071537 | Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors | completed | Phase 1 | 24 | University of CincinnatiOTHER | 1 | Nov 25, 2019 | clinicaltrials |
| NCT00652626 | Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function(RENAL) | completed | Phase 1 | 31 | CelgeneINDUSTRY | 1 | Nov 19, 2019 | clinicaltrials |
| NCT00747474 | Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors | completed | Phase 1 | 54 | Taiwan Liposome CompanyINDUSTRY | 2 | Nov 18, 2019 | clinicaltrials |
| NCT02146222 | VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors | completed | Phase 1 | 14 | University of Wisconsin, MadisonOTHER | 1 | Nov 18, 2019 | clinicaltrials |
| NCT02518958 | A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab(PRIMETIME) | completed | Phase 1 | 12 | EpicentRx, Inc.INDUSTRY | 1 | Nov 18, 2019 | clinicaltrials |
| NCT03057366 | A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors | completed | Phase 1 | 8 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 18, 2019 | clinicaltrials |
| NCT01163071 | A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas | terminated | Phase 1 | 60 | CelgeneINDUSTRY | 1 | Nov 14, 2019 | clinicaltrials |
| NCT02511795 | AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors | completed | Phase 1 | 128 | AstraZenecaINDUSTRY | 2 | Nov 7, 2019 | clinicaltrials |
| NCT04151329 | A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor | unknown | Phase 1 / Phase 2 | 72 | Bio-Thera SolutionsINDUSTRY | 1 | Nov 5, 2019 | clinicaltrials |
| NCT00002677 | Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors | completed | Phase 1 | 24 | University of Maryland, BaltimoreOTHER | 1 | Nov 4, 2019 | clinicaltrials |
| NCT02553499 | Study of MK-1248 With and Without Pembrolizumab (MK-3475) for Participants With Advanced Solid Tumors (MK-1248-001) | terminated | Phase 1 | 37 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 4, 2019 | clinicaltrials |
| NCT04143789 | Evaluation of AP-002 in Patients With Solid Tumors | unknown | Phase 1 / Phase 2 | 61 | Altum Pharmaceuticals INCINDUSTRY | 1 | Oct 31, 2019 | clinicaltrials |
| NCT03897283 | Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid Tumors | unknown | Phase 1 | 22 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Oct 30, 2019 | clinicaltrials |
| NCT04144855 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 Injection | unknown | Phase 1 | 40 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Oct 30, 2019 | clinicaltrials |
| NCT02857166 | Study of JS001 in Participants With Advanced Solid Tumors | completed | Phase 1 | 24 | Shanghai Junshi Bioscience Co., Ltd.OTHER | 1 | Oct 23, 2019 | clinicaltrials |
| NCT03619616 | Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults | completed | Phase 1 | 40 | Guangdong Zhongsheng Pharmaceutical Co., Ltd.INDUSTRY | 1 | Oct 23, 2019 | clinicaltrials |
| NCT02471846 | A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 158 | Genentech, Inc.INDUSTRY | 4 | Oct 22, 2019 | clinicaltrials |
| NCT00635284 | ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies | completed | Phase 1 | 27 | CelgeneINDUSTRY | 1 | Oct 18, 2019 | clinicaltrials |
| NCT02963168 | A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies | unknown | Phase 1 | 24 | Athenex, Inc.INDUSTRY | 1 | Oct 17, 2019 | clinicaltrials |
| NCT03035591 | ODM-207 in Patients With Advance Solid Tumours(BETIDES) | completed | Phase 1 / Phase 2 | 36 | Orion Corporation, Orion PharmaINDUSTRY | 1 | Oct 15, 2019 | clinicaltrials |
| NCT03101839 | Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours | completed | Phase 1 | 28 | AstraZenecaINDUSTRY | 2 | Oct 4, 2019 | clinicaltrials |
| NCT01806675 | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy | completed | Phase 1 / Phase 2 | 25 | Sanjiv Sam GambhirOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT01184326 | Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer | completed | Phase 1 | 23 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 2, 2019 | clinicaltrials |
| NCT02093351 | To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer | completed | Phase 1 | 79 | AstraZenecaINDUSTRY | 5 | Oct 2, 2019 | clinicaltrials |
| NCT03879057 | Trial of Surufatinib Combined With JS001 in the Treatment of Advanced Solid Tumors | unknown | Phase 1 | 24 | Peking UniversityOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT00688415 | Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer | completed | Phase 1 | 33 | CelgeneINDUSTRY | 1 | Sep 25, 2019 | clinicaltrials |
| NCT02559492 | Itacitinib Combined With INCB024360 and/or Itacitinib Combined With INCB050465 in Advanced Solid Tumors | terminated | Phase 1 | 142 | Incyte CorporationINDUSTRY | 1 | Sep 25, 2019 | clinicaltrials |
| NCT02979392 | Phase I Study of TENPA in Advanced Solid Cancer | terminated | Phase 1 | 19 | Yung-Jue BangOTHER | 1 | Sep 25, 2019 | clinicaltrials |
| NCT01135563 | Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours | completed | Phase 1 | 14 | The Hospital for Sick ChildrenOTHER | 2 | Sep 20, 2019 | clinicaltrials |
| NCT02259010 | A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma | completed | Phase 1 | 24 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Sep 20, 2019 | clinicaltrials |
| NCT02759666 | A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors | completed | Phase 1 | 30 | Atridia Pty Ltd.INDUSTRY | 1 | Sep 19, 2019 | clinicaltrials |
Data updated 24 days agoSource updated Jan 10, 2020source: clinicaltrials